troglitazone has been researched along with Cancer of Kidney in 5 studies
Troglitazone: A chroman and thiazolidinedione derivative that acts as a PEROXISOME PROLIFERATOR-ACTIVATED RECEPTORS (PPAR) agonist. It was formerly used in the treatment of TYPE 2 DIABETES MELLITUS, but has been withdrawn due to hepatotoxicity.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (80.00) | 29.6817 |
| 2010's | 1 (20.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| von Schwarzenberg, K | 1 |
| Held, SA | 1 |
| Schaub, A | 1 |
| Brauer, KM | 1 |
| Bringmann, A | 1 |
| Brossart, P | 1 |
| Fujita, M | 1 |
| Yagami, T | 1 |
| Fujio, M | 1 |
| Tohji, C | 1 |
| Takase, K | 1 |
| Yamamoto, Y | 1 |
| Sawada, K | 1 |
| Yamamori, M | 1 |
| Okamura, N | 1 |
| Yang, FG | 2 |
| Zhang, ZW | 2 |
| Xin, DQ | 2 |
| Shi, CJ | 2 |
| Wu, XQ | 1 |
| Liu, WJ | 1 |
| Guo, YL | 2 |
| Wu, JP | 2 |
| Guan, YF | 1 |
| Inoue, K | 1 |
| Kawahito, Y | 1 |
| Tsubouchi, Y | 1 |
| Kohno, M | 1 |
| Yoshimura, R | 1 |
| Yoshikawa, T | 1 |
| Sano, H | 1 |
5 other studies available for troglitazone and Cancer of Kidney
| Article | Year |
|---|---|
Proteasome inhibition overcomes the resistance of renal cell carcinoma cells against the PPARgamma ligand troglitazone.
Topics: Angiogenesis Inducing Agents; Antineoplastic Agents; Apoptosis; Boronic Acids; Bortezomib; Carcinoma | 2009 |
Cytotoxicity of troglitazone through PPARĪ³-independent pathway and p38 MAPK pathway in renal cell carcinoma.
Topics: Antineoplastic Agents; Blotting, Western; Carcinoma, Renal Cell; Cell Line, Tumor; Chromans; Humans; | 2011 |
[Peroxisome proliferator-actived receptor-gamma ligand troglitazone induces apoptosis in renal cell carcinoma].
Topics: Antineoplastic Agents; Apoptosis; Carcinoma, Renal Cell; Cell Line, Tumor; Chromans; Humans; Kidney | 2004 |
Peroxisome proliferator-activated receptor gamma ligands induce cell cycle arrest and apoptosis in human renal carcinoma cell lines.
Topics: Antineoplastic Agents; Apoptosis; Carcinoma, Renal Cell; Cell Line, Tumor; Cell Proliferation; Chrom | 2005 |
Expression of peroxisome proliferator-activated receptor gamma in renal cell carcinoma and growth inhibition by its agonists.
Topics: Antineoplastic Agents; Blotting, Western; Carcinoma, Renal Cell; Cell Division; Chromans; Coloring A | 2001 |